Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know

References

• van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 2017; 8(4):460-469; PMID:27593176; https://doi.org/10.1080/21505594.2016.1222343
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE). November 2015 Update - CRE Toolkit wwwcdcgov 2015.
   Google Scholar
• Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A, Simner PJ. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia. Clin Infect Dis 2017; 64:257-64; PMID:28013264; https://doi.org/10.1093/cid/ciw741
   PubMed Web of Science ®Google Scholar
• van Duin D, Perez F, Rudin SD, Cober E, Hanrahan J, Ziegler J, Webber R, Fox J, Mason P, Richter SS, et al. Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network. Antimicrob Agents Chemother 2014; 58:4035-41; PMID:24798270; https://doi.org/10.1128/AAC.02636-14
   PubMed Web of Science ®Google Scholar
• Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J, Wilson LE, Vaeth E, Lynfield R, Shaw KM, et al. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012–2013. JAMA 2015; 314:1479-87; PMID:26436831; https://doi.org/10.1001/jama.2015.12480
   PubMed Web of Science ®Google Scholar
• Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, et al. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections. Clin Microbiol Infect 2016; 22:513-9; PMID:26850824; https://doi.org/10.1016/j.cmi.2016.01.023
   PubMed Web of Science ®Google Scholar
• van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Jr., Kaye KS, Bonomo RA. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae. J Antimicrob Chemother 2015; 70:1203-11; PMID:25492391
   PubMed Web of Science ®Google Scholar
• van Duin D, Cober ED, Richter SS, Perez F, Cline M, Kaye KS, Kalayjian RC, Salata RA, Evans SR, Fowler VG, Jr., et al. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance. Clin Microbiol Infect 2014; 20:O1117-20; PMID:24931918; https://doi.org/10.1111/1469-0691.12714
   PubMed Web of Science ®Google Scholar
• Qureshi ZA, Syed A, Clarke LG, Doi Y, Shields RK. Epidemiology and Clinical Outcomes of Patients with Carbapenem-Resistant Klebsiella pneumoniae Bacteriuria. Antimicrob Agents Chemother 2014; 58:3100-4; PMID:24637691; https://doi.org/10.1128/AAC.02445-13
   PubMed Web of Science ®Google Scholar
• Perez F, van Duin D. Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients. Cleve Clin J Med 2013; 80:225-33; PMID:23547093; https://doi.org/10.3949/ccjm.80a.12182
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Tracking CRE. http://wwwcdcgov/hai/organisms/cre/TrackingCREhtml; 2016; accessed 5/23/2016.
   Google Scholar
• Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL. European Survey of Carbapenemase-Producing Enterobacteriaceae working g. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill 2015; 20; PMID:26675038; https://doi.org/10.2807/1560-7917.ES.2015.20.45.30062
   PubMedGoogle Scholar
• Pouch SM, Satlin MJ. Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence 2017; 8(4):391-402; PMID:27470662; https://doi.org/10.1080/21505594.2016.1213472
   PubMed Web of Science ®Google Scholar
• Wong D, Spellberg B. Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant enterobacteriaceae. Virulence 2017; 8(4):383-390; https://doi.org/10.1080/21505594.2016.1188234.
   PubMed Web of Science ®Google Scholar
• Richter SS, Marchaim D. Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How? Virulence 2017; 8(4):417-426; PMID:27813699; https://doi.org/10.1080/21505594.2016.1255381
   PubMed Web of Science ®Google Scholar
• Banerjee R, Humphries R. Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae. Virulence 2017; 8(4):427-439; PMID:27168451; https://doi.org/10.1080/21505594.2016.1185577
   PubMed Web of Science ®Google Scholar
• Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, Shah ND, Mandrekar JN, Patel R. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing. Clin Infect Dis 2015; 61:1071-80; PMID:26197846; https://doi.org/10.1093/cid/civ447
   PubMed Web of Science ®Google Scholar
• Neuner EA, Gallagher JC. Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae. Virulence 2017; 8(4):440-452; PMID: 27589330; https://doi.org/10.1080/21505594.2016.1221021
   PubMed Web of Science ®Google Scholar
• Thaden JT, Pogue JM, Kaye KS. Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae. Virulence 2017; 8(4):403-416; PMID:27384881; https://doi.org/10.1080/21505594.2016.1207834
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, et al. Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy. Clin Infect Dis 2012; 55:943-50.
   PubMed Web of Science ®Google Scholar
• van Duin D, Bonomo RA. Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation beta-Lactam/beta-Lactamase Inhibitor Combinations. Clin Infect Dis 2016; 63:234-41; PMID:27098166; https://doi.org/10.1093/cid/ciw243
   PubMed Web of Science ®Google Scholar
• Wu G, Abraham T, Lee S. Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Bacteremia. Clin Infect Dis 2016; 63(8):1147-8.
   PubMed Web of Science ®Google Scholar
• Shields RK, Potoski BA, Haidar G, Hao B, Doi Y, Chen L, Press EG, Kreiswirth BN, Clancy CJ, Nguyen MH. Clinical outcomes, drug toxicity and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections. Clin Infect Dis 2016; 63(12):1615-8; PMID:27624958
   PubMed Web of Science ®Google Scholar
• Evans SR, Harris AD. Methods and Issues in Studies of CRE. Virulence 2017; 8(4):453-459; https://doi.org/10.1080/21505594.2016.1213473 .
   PubMed Web of Science ®Google Scholar